Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiple Loci modulate opioid therapy response for cancer pain.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Jul 2011

Galvan Antonella, Skorpen Frank, Klepstad Pål, Knudsen Anne Kari, Fladvad Torill, Falvella Felicia S, Pigni Alessandra, Brunelli Cinzia, Caraceni Augusto, Kaasa Stein, Dragani Tommaso A

Abstract excerpt

PURPOSE: Patients treated with opioid drugs for cancer pain experience different relief responses, raising the possibility that genetic factors play a role in opioid therapy outcome. In this study, we tested the hypothesis that genetic variations may control individual response to opioid drugs in cancer patients. EXPERIMENTAL DESIGN: We tested 1 million single-nucleotide polymorphisms (SNP) in European cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Analgesics, Opioid
Share to Gene Expression Profiling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Loci

Share to Neoplasms

Share to Serine Endopeptidases

Share to Serine Proteases

Share to Treatment Outcome

Source

Identifiers

PMID: 21622719
DOI: 10.1158/1078-0432.CCR-10-3028

Genes

RHBDF2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiple Loci modulate opioid therapy response for cancer pain.PMID 21622719Read ↗

Evaluating the Use of Tumor Bank DNA to Validate Genetic Factors Impacting Opioid Response in Patients with Advanced Cancer.Semantic proximity Read ↗

Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients.Semantic proximity Read ↗

Genetics and Opioids: Towards More Appropriate Prescription in Cancer PainSemantic proximity Read ↗

A European pharmacogenomic study of the response to opioids in advanced cancer patients identifies germline variants associated with nausea-vomiting side effectSemantic proximity Read ↗

A genome-wide association study of European advanced cancer patients treated with opioids identifies regulatory variants on chromosome 20 associated with pain intensity.Semantic proximity Read ↗

Clinical Implications of Opioid Pharmacogenomics in Patients With Cancer.Semantic proximity Read ↗

Lack of association between genetic variability and multiple pain-related outcomes in a large cohort of patients with advanced cancer: the European Pharmacogenetic Opioid Study (EPOS).Semantic proximity Read ↗

Understanding the genetic determinants of pain and pain management.Semantic proximity Read ↗

Genetic and pharmacogenomic influences on cancer pain management : A scoping reviewSemantic proximity Read ↗

Genome-wide association study identifies a potent locus associated with human opioid sensitivity.Semantic proximity Read ↗

Genetic Factors Associated With Pain Severity, Daily Opioid Dose Requirement, and Pain Response Among Advanced Cancer Patients Receiving Supportive Care.Semantic proximity Read ↗

Genetic clustering of European cancer patients indicates that opioid-mediated pain relief is independent of ancestry.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.